DRUG RESISTANCE IN CANCER CHEMOTHERAPY- AN OVERVIEW -

作者: Somervell Memorial Csi , Ambili Remesh

DOI:

关键词: BioinformaticsDrugCombination chemotherapyDrug resistancePharmacologyBiologyMultiple drug resistanceChemotherapyMechanism (biology)Membrane permeabilityPharmacokinetics

摘要: Drug resistance is one of the primary obstacles in cancer chemotherapy. The causes drug resistances are varied. attributed to genomic instability while alteration membrane permeability and inability reach target sites, inactivation by enzymes, mutation altered expression proteins there affecting interactions some mechanism acquired resistance. In addition genetic changes epigenetic or non mutational mechanisms which occur quickly response environmental changes. Normal tissues never develop chemotherapy, because they possess intact machinery. reducing clinical effectiveness, result early termination treatment, reduced relapse free interval survival. There various methods for overcoming these major disadvantages Combination chemotherapy with clear understanding biochemical, molecular pharmacokinetic interaction between individual drugs a given combination method. Optimal scheduling also strategy controlling therapy. Control avenues administration dose intensification provide better outcome. Despite measures overcome resistance, problem especially multidrug still casting its shadow successful A links will open up new circumventing this fundamental prolong life expectancy patient. This article gives an overview encountered

参考文章(16)
L L Nielsen, D C Maneval, P53 tumor suppressor gene therapy for cancer. Cancer Gene Therapy. ,vol. 5, pp. 52- 63 ,(1998)
Bertram G. Katzung, Basic And Clinical Pharmacology ,(1982)
Hsing-Pang Lu, CC Chao, None, Cancer cells acquire resistance to anticancer drugs: An update Biomedical journal. ,vol. 35, pp. 464- 472 ,(2012) , 10.4103/2319-4170.104411
Robert L. Souhami, Jeffrey S. Tobias, Cancer and Its Management ,(1986)
Philippe Szankasi, Heather M. Dunstan, Stephen H. Friend, Julian A. Simon, Elizabeth L. Jensen, Di K. Nguyen, Catherine Ludlow, Leland H. Hartwell, Christopher J. Roberts, Differential Toxicities of Anticancer Agents among DNA Repair and Checkpoint Mutants of Saccharomyces cerevisiae Cancer Research. ,vol. 60, pp. 328- 333 ,(2000)
Gary D Kruh, Introduction to resistance to anticancer agents. Oncogene. ,vol. 22, pp. 7262- 7264 ,(2003) , 10.1038/SJ.ONC.1206932
M Mimeault, R Hauke, SK Batra, Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. Clinical Pharmacology & Therapeutics. ,vol. 83, pp. 673- 691 ,(2008) , 10.1038/SJ.CLPT.6100296
Clemens A. Schmitt, Scott W. Lowe, Apoptosis and therapy The Journal of Pathology. ,vol. 187, pp. 127- 137 ,(1999) , 10.1002/(SICI)1096-9896(199901)187:1<127::AID-PATH251>3.0.CO;2-T
Robert A. Weinberg, How Cancer Arises Scientific American. ,vol. 275, pp. 62- 70 ,(1996) , 10.1038/SCIENTIFICAMERICAN0996-62